Covered recipient · General Payments record
PHILIP KLINE
General Payments · PY2018–2019
$622.92
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $240.87 | 17 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $128.15 | 11 |
| Celularity Inc. | $41.00 | 1 |
| Vertical Pharmaceuticals, LLC | $27.03 | 2 |
| Allergan Inc. | $17.06 | 1 |
| TherapeuticsMD, Inc. | $14.33 | 1 |
| ABBVIE INC. | $13.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (17)
Sorted by paying entity, then date · as published by CMS
Program year 2019 2018
Record-level detail is published for PY2019; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | $13.30 | 03/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | 696062953 | CMS |
| Allergan Inc. | $17.06 | 01/28/2019 | Food and Beverage | Undisputed | 01/23/2026 | 670667451 | CMS |
| Celularity, Inc. | $41.00 | 04/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 690772295 | CMS |
| PFIZER INC. | $12.57 | 02/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | 671898787 | CMS |
| PFIZER INC. | $10.61 | 02/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | 673228991 | CMS |
| PFIZER INC. | $5.11 | 03/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | 673041533 | CMS |
| PFIZER INC. | $3.66 | 04/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | 673040853 | CMS |
| PFIZER INC. | $12.53 | 06/25/2019 | Food and Beverage | Undisputed | 01/23/2026 | 672148089 | CMS |
| PFIZER INC. | $15.31 | 07/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | 672402135 | CMS |
| PFIZER INC. | $12.69 | 08/06/2019 | Food and Beverage | Undisputed | 01/23/2026 | 672528779 | CMS |
| PFIZER INC. | $14.98 | 09/10/2019 | Food and Beverage | Undisputed | 01/23/2026 | 673197627 | CMS |
| PFIZER INC. | $14.98 | 09/24/2019 | Food and Beverage | Undisputed | 01/23/2026 | 673197629 | CMS |
| PFIZER INC. | $13.40 | 10/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | 673228993 | CMS |
| PFIZER INC. | $12.31 | 11/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | 673823747 | CMS |
| TherapeuticsMD, Inc. | $14.33 | 03/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 703061739 | CMS |
| Vertical Pharmaceuticals, LLC | $13.99 | 03/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | 675505017 | CMS |
| Vertical Pharmaceuticals, LLC | $13.04 | 07/01/2019 | Food and Beverage | Undisputed | 01/23/2026 | 675505019 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.